Holen Sie sich die Stockscreener-App
140.08
0.30%
0.37
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt GILD?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Gilead Sciences Inc Aktie (GILD) Neueste Nachrichten
Trump Imposes 100% Drug Tariffs: 5 Pharma Stocks That Won’t Pay a Dime - Investing.com
Gilead Has Fallen 11% From Its 52-Week High. Is Now the Time to Buy GILD? - TIKR.com
Cantor Fitzgerald reiterates Gilead Sciences stock rating at overweight By Investing.com - Investing.com India
Gilead Sciences, Inc. (GILD) Stock Price, News, Quote & History - Yahoo! Finance Canada
Kelleher Financial Advisors Increases Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Meridian Investment Counsel Inc. Has $3.94 Million Stock Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Perpetual Ltd Raises Position in Gilead Sciences, Inc. $GILD - MarketBeat
Galapagos NV (GLPG) Signs Agreement with Gilead on Ouro Medicines Assets - Yahoo Finance
Gilead Sciences, Inc. (GILD) Galapagos NV,M&A CallSlideshow (NASDAQ:GILD) 2026-04-03 - Seeking Alpha
Gilead Sciences, Inc. $GILD Position Reduced by Aberdeen Group plc - MarketBeat
Layoff Tracker: Gilead Lays Off Employees at California Headquarters - BioSpace
Bristol Myers Squibb and Gilead Sciences are putting their media accounts into review - adage.com
Gilead Sciences, Inc. (GILD.NE) recent insider transactions - Yahoo Finance UK
Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know - Yahoo Finance
Gilead Refuses to Sell Groundbreaking HIV Prevention Drug to MSF - marketscreener.com
HF Advisory Group LLC Buys 13,212 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
MSF Seeks Access to Breakthrough HIV Drug, But Gilead Refuses - allAfrica.com
Africa: Gilead Under Fire for Not Selling HIV Drug Lenacapavir to MSF - allAfrica.com
Bank Pictet & Cie Europe AG Purchases 136,605 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Banque Pictet & Cie SA Purchases 142,543 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Allspring Global Investments Holdings LLC Purchases 71,872 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
A Look At Gilead Sciences (GILD) Valuation After Recent Mixed Share Price Performance - Yahoo Finance
Nomura VIP Core Equity Series's Gilead Sciences Inc(GILD) Holding History - GuruFocus
Gilead to acquire Ouro Medicines in $2.18B deal, expand inflammation pipeline - MSN
Morgan Stanley Reaffirms Overweight on Gilead Sciences, Inc. (GILD), Citing LEN Potential - MSN
Gilead extends Arcellx tender offer expiration date - MSN
Gilead (NASDAQ: ACLX) extends $115 per‑share tender, CVR pays $5 on condition - Stock Titan
Gilead Extends Tender Offer to Acquire Arcellx - Business Wire
Gilead Sciences Supports the LGBTQ+ Community in Oakland: Love Is the Answer - ACCESS Newswire
Gilead Sciences's Q1 2026 Earnings: What to Expect - Yahoo Finance
Gilead Sciences Inc Stock (GILD) Moved Up by 3.03% on Apr 1: Facts Behind the Movement - TradingKey
Gilead Sciences, Inc. $GILD Shares Acquired by Moody Lynn & Lieberson LLC - MarketBeat
Gilead Sciences, Inc. $GILD Stock Holdings Raised by Nisa Investment Advisors LLC - MarketBeat
Meyer Handelman Co. Has $41.33 Million Holdings in Gilead Sciences, Inc. $GILD - MarketBeat
Shrier Wealth Management LLC Buys Shares of 14,244 Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Sciences (GILD) Rises Yet Lags Behind Market: Some Facts Worth Knowing - Yahoo Finance
Gilead Sciences Acquires Ouro Medicines for $2.2 Billion to Lead 'Immune Reset' Revolution - FinancialContent
Gilead Sciences Inc. stock rises Tuesday, still underperforms market - marketwatch.com
Bernstein Maintains Gilead Sciences(GILD.US) With Buy Rating, Raises Target Price to $160 - Moomoo
UBS reiterates Gilead Sciences stock rating on strong Yeztugo sales - Investing.com
Gilead Sciences Inc Stock (GILD) Moved Up by 3.62% on Mar 31: A Full Analysis - TradingKey
Gilead and its new HIV prevention drug are in the sights of a well-known humanitarian group - The Business Journals
MSF denied access to Gilead HIV-prevention drug - EU Reporter
J. Safra Sarasin Holding AG Trims Gilead Sciences Stake - National Today
Gilead (GILD) Enters Agreement to Acquire Ouro Medicines - GuruFocus
Gilead Sciences, Inc. $GILD Shares Bought by Mn Services Vermogensbeheer B.V. - MarketBeat
Boston Common Asset Management LLC Sells 15,833 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
Gilead Expands Autoimmune Ambitions With Ouro Deal And Galapagos Collaboration - Yahoo Finance
Galapagos and Gilead Enter into Binding Agreement to Collaborate on Advancing First in Class T Cell Engager Program for Autoimmune Diseases - The Manila Times
Insider Sell: Daniel O'Day Sells 10,000 Shares of Gilead Sciences Inc (GILD) - GuruFocus
Biotech deal-O-rama, Gilead and Tallon’s U.K. vision — a BioCentury podcast - biocentury.com
[Press release] Médecins Sans Frontières: Gilead refuses to sell groundbreaking HIV prevention drug to MSF - European AIDS Treatment Group
Gilead Sciences (NASDAQ: GILD) CEO sells 10,000 shares under 10b5-1 plan - Stock Titan
Gilead Sciences Inc. stock outperforms competitors on strong trading day - marketwatch.com
Doctors Without Borders calls Gilead 'unconscionable' for refusing to sell HIV prevention drug to organization - statnews.com
Gilead refuses to sell groundbreaking HIV prevention drug to MSF - MSF Access
Open letter to Gilead: Prevention should not be a privilege - Doctors Without Borders
Beacon Investment Advisory Services Inc. Buys 10,449 Shares of Gilead Sciences, Inc. $GILD - MarketBeat
$1000 Invested In Gilead Sciences 20 Years Ago Would Be Worth This Much Today - Sahm
Gilead Sciences Sees Surge in Institutional Investment - National Today
0.99%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):